Medicine

It occurred after one of the volunteers showed a side effect.

The publication summarizes the results of trials in humans and mentions previously unpublished data on preclinical studies in animals.

The organization noted that vaccine research should be conducted in accordance with established procedures at every stage of development to ensure the safety and efficacy of drug.

The drug was developed by the Gamaleya National Research Center for Epidemiology and Microbiology.

According to the head of the Russian Direct Investment Fund, Kirill Dmitriyev, Russia by the end of 2020 can release and deliver more than 200 million doses of the drug to different countries.

All volunteers began to generate antibodies to SARS-CoV-2.

According to Alexander Gintsburg, it may occur in mid-August.

The final stage of clinical trials of the coronavirus vaccine, which are jointly conducted by the Gamalei national research center and the Russian defense Ministry, has begun, the military Department reported.

“It was all frozen, and now it is melting,” Sergey Davydov explained.

According to Rinat Maksyutov, they have been successfully tested for their ability to form an immune response.

Rospotrebnadzor specialists prepared a memo for the Russians, in which they told about the danger of tick bites and diseases they carry.

Russia will not be the first country to get a COVID-19 vaccine from China.

Dexamethasone reduces mortality of patients on mechanical ventilation by 35 %, and people on oxygen treatment by 20 %.

The drug will be free for Russians under the compulsory health insurance program

The number of infected doubled in just over a month